Medical device licence · 62080 · Class 2
CD3 PRIMARY ANTIBODY (POLYCLONAL)
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed March 18, 2003; ended October 29, 2004. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 62080
- Licence holder
- Ventana Medical Systems IncTucson, AZ, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Single Device
- First licensed
- March 18, 2003
- Ended
- October 29, 2004
- Devices covered
- 1
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- CD3 PRIMARY ANTIBODY (POLYCLONAL)
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.